FDA Watching For “Unintended Consequences” of 21st Century Cures
This article was originally published in RPM Report
Executive Summary
Engaging in the House Energy & Commerce Committee’s “21st Century Cures” process and tracking any potential legislation will be a top priority in 2015, FDA’s Janet Woodcock says. Sometimes what seem like good ideas, she says, “have a lot of unintended consequences.”